Target: Mark Shkreli, CEO of Turing Pharmaceuticals
Goal: Lower price of the life-saving drug Daraprim to an affordable and reasonable price.
The drug Daraprim has been used to treat a life-threatening parasitic disease for decades, but now a young man owns the rights to it, and he raised the drug’s price from an affordable $13.50 a tablet to $750 overnight. The drug is used to treat toxoplasmosis, a parasitic infection that often causes life-threatening problems for babies whose mother was infected during pregnancy, as well as those with compromised immune systems — particularly cancer and AIDS patients.
This disgusting greed will only make the drug less available to those who cannot afford it and there’s no reason for this. The ridiculous price increase could also cause hospitals to be forced to turn to less effective treatment methods.
People without healthy immune systems, like those with AIDS and cancer, can die without this drug. Please demand that the price be lowered to a more reasonable and affordable one.
Dear Mark Shkreli, CEO of Turing Pharmaceuticals,
It has come to our attention that you increased the price of the life-saving drug, Daraprim from an affordable $13.50 to $750 per tablet. This ridiculous overnight increase means that people at risk won’t be able to afford the necessary treatment. It could also cause hospitals to be forced to turn to less effective treatment methods.
It’s clear that this insanely huge price increase comes from pure greed and it’s sad that you’d rather line your pockets than save people’s lives. We urge you to make the right decision and lower the price of the drug so that it’s affordable to those who need it.
[Your Name Here]
Photo credit: Charles Williams